JP2022537562A5 - - Google Patents
Info
- Publication number
- JP2022537562A5 JP2022537562A5 JP2021575438A JP2021575438A JP2022537562A5 JP 2022537562 A5 JP2022537562 A5 JP 2022537562A5 JP 2021575438 A JP2021575438 A JP 2021575438A JP 2021575438 A JP2021575438 A JP 2021575438A JP 2022537562 A5 JP2022537562 A5 JP 2022537562A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- construct
- fragment
- variant
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025081437A JP2025118871A (ja) | 2019-06-18 | 2025-05-14 | Ｒｎａ構築物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1908729.5A GB201908729D0 (en) | 2019-06-18 | 2019-06-18 | RNA construct |
| GB1908729.5 | 2019-06-18 | ||
| PCT/GB2020/051465 WO2020254804A1 (en) | 2019-06-18 | 2020-06-18 | Rna construct |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025081437A Division JP2025118871A (ja) | 2019-06-18 | 2025-05-14 | Ｒｎａ構築物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022537562A JP2022537562A (ja) | 2022-08-26 |
| JP2022537562A5 true JP2022537562A5 (https=) | 2023-06-22 |
Family
ID=67432317
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575438A Pending JP2022537562A (ja) | 2019-06-18 | 2020-06-18 | Ｒｎａ構築物 |
| JP2025081437A Pending JP2025118871A (ja) | 2019-06-18 | 2025-05-14 | Ｒｎａ構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025081437A Pending JP2025118871A (ja) | 2019-06-18 | 2025-05-14 | Ｒｎａ構築物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12569548B2 (https=) |
| EP (1) | EP3987042A1 (https=) |
| JP (2) | JP2022537562A (https=) |
| KR (1) | KR20220038669A (https=) |
| CN (1) | CN114402078B (https=) |
| AU (1) | AU2020296337B2 (https=) |
| BR (1) | BR112021024786A2 (https=) |
| CA (1) | CA3143117A1 (https=) |
| GB (1) | GB201908729D0 (https=) |
| IL (1) | IL288956A (https=) |
| MX (1) | MX2021015753A (https=) |
| WO (1) | WO2020254804A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110168093B (zh) * | 2017-09-12 | 2023-08-15 | 中科蓝华(广州)生物医药技术有限公司 | 一种转染细胞内寄生虫的试剂盒及其应用 |
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| US20210369759A1 (en) * | 2020-01-29 | 2021-12-02 | Helix Nanotechnologies, Inc. | METHODS AND COMPOSITIONS FOR NUCLEIC ACID EXPRESSION INVOLVING INHIBITION of NF-kB PATHWAYS AND/OR IRF PATHWAYS |
| AU2021236068A1 (en) | 2020-03-09 | 2022-10-06 | Arcturus Therapeutics, Inc. | Compositions and methods for inducing immune responses |
| KR20220156933A (ko) | 2020-03-23 | 2022-11-28 | 에이치디티 바이오 코포레이션 | Rna의 전달을 위한 조성물 및 방법 |
| EP4196128A4 (en) | 2020-08-14 | 2024-06-12 | Arcturus Therapeutics, Inc. | METHOD FOR FREEZE DILIZATION OF LIPID NANOPARTICLES |
| GB202020061D0 (en) * | 2020-12-17 | 2021-02-03 | Imp College Innovations Ltd | RNA construct |
| EP4267593A2 (en) | 2020-12-23 | 2023-11-01 | GlaxoSmithKline Biologicals SA | Self-amplifying messenger rna |
| US20240240201A1 (en) | 2021-05-04 | 2024-07-18 | Mogrify Limited | Cell conversion |
| CN113249408B (zh) * | 2021-06-23 | 2021-11-02 | 深圳湾实验室 | 一种靶向激活体液免疫和细胞免疫的核酸疫苗载体构建及应用 |
| JP2024535354A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | がん治療組成物およびその使用 |
| CA3232719A1 (en) | 2021-09-22 | 2023-03-30 | Steven Gregory REED | Sars-cov-2 rna vaccine compositions and methods of use |
| WO2023048760A1 (en) | 2021-09-22 | 2023-03-30 | Hdt Bio Corp. | Rna vaccines against infectious diseases |
| EP4404919A4 (en) | 2021-09-22 | 2025-08-20 | Hdt Bio Corp | DRIED NANOPARTICLE COMPOSITIONS |
| CN118715325A (zh) * | 2021-12-17 | 2024-09-27 | 帝国理工创新有限公司 | Rna构建体 |
| GB202203060D0 (en) | 2022-03-04 | 2022-04-20 | Imperial College Innovations Ltd | RNA molecule |
| CN119563028A (zh) * | 2022-05-12 | 2025-03-04 | 尚威天成信使核糖核酸治疗公司 | 具有分泌抗原和免疫调节物的合成自扩增mRNA分子 |
| CN115820696A (zh) * | 2022-07-28 | 2023-03-21 | 怡道生物科技(苏州)有限公司 | 治疗性多价HPV mRNA疫苗及其制备方法 |
| KR20240133629A (ko) * | 2023-02-27 | 2024-09-04 | 주식회사 마이크로유니 | 자가 증폭 rna 컨스트럭트 및 이의 용도 |
| WO2025008641A2 (en) | 2023-07-06 | 2025-01-09 | Imperial College Innovations Limited | Rna molecule |
| CN121586776A (zh) * | 2023-07-19 | 2026-02-27 | 上海复诺健生物科技有限公司 | 自扩增核酸分子及其应用 |
| GB202313445D0 (en) | 2023-09-04 | 2023-10-18 | Imperial College Innovations Ltd | Rna molecule |
| WO2025217136A2 (en) * | 2024-04-08 | 2025-10-16 | Amplitude Therapeutics, Inc. | Trans-amplifying rnas encoding immunomodulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110117124A1 (en) | 2007-08-31 | 2011-05-19 | Sadoff Jerald C | Enhancement of transgene expression from viral-based vaccine vectors by expression of suppressors of the type i interferon response |
| US7608256B2 (en) | 2007-09-12 | 2009-10-27 | Aeras Global Tb Vaccine Foundation | Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |
| US20140037680A1 (en) * | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| TR201809547T4 (tr) * | 2012-11-09 | 2018-07-23 | Biontech Rna Pharmaceuticals Gmbh | Hücresel RNA ifadesine yönelik yöntem. |
| GB2592821B (en) * | 2015-07-31 | 2022-01-12 | Univ Minnesota | Modified cells and methods of therapy |
| CA3045650A1 (en) * | 2016-12-05 | 2018-06-14 | Janssen Pharmaceuticals, Inc. | Compositions and methods for enhancing gene expression |
-
2019
- 2019-06-18 GB GBGB1908729.5A patent/GB201908729D0/en not_active Ceased
-
2020
- 2020-06-18 MX MX2021015753A patent/MX2021015753A/es unknown
- 2020-06-18 US US17/617,831 patent/US12569548B2/en active Active
- 2020-06-18 JP JP2021575438A patent/JP2022537562A/ja active Pending
- 2020-06-18 CA CA3143117A patent/CA3143117A1/en active Pending
- 2020-06-18 KR KR1020227001607A patent/KR20220038669A/ko active Pending
- 2020-06-18 AU AU2020296337A patent/AU2020296337B2/en active Active
- 2020-06-18 WO PCT/GB2020/051465 patent/WO2020254804A1/en not_active Ceased
- 2020-06-18 EP EP20734803.8A patent/EP3987042A1/en active Pending
- 2020-06-18 CN CN202080045184.7A patent/CN114402078B/zh active Active
- 2020-06-18 BR BR112021024786A patent/BR112021024786A2/pt unknown
-
2021
- 2021-12-13 IL IL288956A patent/IL288956A/en unknown
-
2025
- 2025-05-14 JP JP2025081437A patent/JP2025118871A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537562A5 (https=) | ||
| US20210330781A1 (en) | Induce and enhance immune responses using recombinant replicon systems | |
| US8840899B2 (en) | Use of mTOR inhibitors to enhance T cell immune responses | |
| JP2020010711A (ja) | Ｍｄｃｋ、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス | |
| JP2023551982A (ja) | マルチシストロン性ｒｎａワクチン及びその使用 | |
| US12533404B2 (en) | Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases | |
| CN112552379B (zh) | 合成肽在制备防治新型冠状病毒感染药物中的用途 | |
| JP2024535145A (ja) | 改変ワクシニアウイルスアンカラ（ｍｖａ）による細胞傷害性導入遺伝子発現を下方調節するためのマイクロｒｎａの利用 | |
| CN103352029A (zh) | 一种乙脑/森林脑炎嵌合病毒及其应用 | |
| EP3158059B1 (en) | Method for rapid generation of an attenuated rna virus | |
| Hidajat et al. | Next generation sequencing of DNA-launched Chikungunya vaccine virus | |
| JP2022512754A5 (https=) | ||
| JP2024546964A5 (https=) | ||
| Yonemitsu et al. | Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen | |
| RU2022100963A (ru) | Рнк-конструкция | |
| CN115975053B (zh) | 靶向新型冠状病毒的疫苗 | |
| Dai et al. | Inhibition of ERK/MAPK suppresses avian leukosis virus subgroup A and B replication | |
| CN111748530B (zh) | 一种提高猪繁殖与呼吸综合征病毒体外培养感染量的方法及其应用 | |
| EP3046936A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| CN103865890B (zh) | 一种用于预防病毒性心肌炎的重组病毒及其疫苗和应用 | |
| CN110256536B (zh) | 一种抗丙型肝炎病毒感染合成肽及其应用 | |
| JPWO2018092887A1 (ja) | 非感染性パラミクソウイルス粒子を用いた感染症ワクチン | |
| WO2025149032A1 (en) | Respiratory syncytial virus vaccine compositions and their use | |
| Opitz et al. | Prophylactic and therapeutic antiviral effects of the influenza A defective interfering particle OP7 in human lung epithelial cells in vitro | |
| Faulkner | Defining Determinants of Viral Membrane Protein Immunogenicity |